Find a Doctor
Dr. David Sallman is an Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center. Dr. Sallman’s clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN). Dr. Sallman earned his MD degree from the University of South Florida College of Medicine. He completed an Internal Medicine Residency at Massachusetts General Hospital and, most recently, a Hematology/Oncology Fellowship at Moffitt Cancer Center. His research interests focus on the development of novel, targeted therapeutic strategies (Phase I and II clinical trials) for patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), based on the underlying mutational drivers of each disease.
Education & Training
Start Year: 2015 End Year: 2017 Evans Fellow of the MDS Clinical Research Consortium, Sponsor: Evans Foundation
Start Year: 2016 End Year: 2016 Moffitt Institutional Trainee Award 2016, Sponsor: Moffitt Cancer Center
Start Year: 2016 End Year: 2016 Best Abstract Award Winner 2016, Sponsor: Moffitt Cancer Center Research Symposium
Start Year: 2015 End Year: 2015 Young Investigator , Sponsor: Alpine Oncology Foundation
Start Year: 2015 End Year: 2015 Clinical Research Training Institute (CRTI) Participant, Sponsor: ASH
Start Year: 2015 End Year: 2015 Best Abstract Award Winner 2015 , Sponsor: Moffitt Cancer Center Research Symposium
Start Year: 2014 End Year: 2014 Workshop Methods in Clinical Cancer Participant, Sponsor: AACR/ASCO
Start Year: 2010 End Year: 2010 Silbiger Research Scholarship Award Winner , Sponsor: USF Health Morsani College of Medicine
Start Year: 2010 End Year: 2010 Roy. H. Behnke, MD Award for Excellence in Internal Medicine, Sponsor: USF Health Morsani College of Medicine
Start Year: 2010 End Year: 2010 Florida American College of Physicians Award, Sponsor: American College of Physicians
Start Year: 2010 End Year: 2010 Academic Excellence Award, Sponsor: USF Health Morsani College of Medicine
Start Year: 2007 End Year: 2007 King O’ Neal Scholar Award – (Summa Cum Laude), Sponsor: USF
CLINICAL TRIAL 19658
CLINICAL TRIAL 20552
CLINICAL TRIAL 20716
CLINICAL TRIAL 20749
CLINICAL TRIAL 19862
Title: Phase 1-Open-Label-Dose-Escal w Expansion Study-SX-682 in Subjects w Myelodysplastic Syndrome w Disease Progression or Intolerant to Prior Therapy
112 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive
different surveys, and the volume of responses will vary by question.
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.Learn more about our patient comments
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including: